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Abstract 
Adequate nutrition is vital for immune homeostasis. However, the incidence of obesity is increasing worldwide due to the adoption of the Western 
diet and a sedentary lifestyle. Obesity is associated with chronic inflammation which alters the function of adipose tissue, liver, pancreas, and the nervous 
system. Inflammation is related to cellular senescence, distinguished by irreversible cell cycle arrest. Senescent cells secrete the senescence-associated 
secretory phenotype (SASP) which contains pro-inflammatory factors. Targeting processes in senescence might have a salutary approach to obesity. The 
present review highlights the impact of an unhealthy diet on tissues affected by obesity, and the mechanisms that promote the consequent inflammation 
and senescence. 
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Chronic over-nutrition, distinguished by an extended positive
energy variance that facilitates obesity, is a risk factor for the
development of multiple health problems (i.e., diabetes, non-
alcoholic fatty liver disease (NAFLD), leaky gut, neuropsychiatric
disorders, cancer, etc.) [1-5] . The World Health Organization de-
fines overweight and obesity as abnormal or excessive fat accu-
mulation that may harm health. Additionally, the prevalence and
increase of people with obesity have led to consider it as a dan-
gerous disease worldwide [6] . Although the causes of obesity are
multifactorial, it is well established that diet is a key player in the
equation. Indeed, current lifestyle changes with a more sedentary
lifestyle and the consumption of highly processed foods, and food
with high fat and low water content or poor in nutrients, encour-
age fat accumulation and the development of overweight and obe-
sity [7] . By contrast, the consumption of a healthy diet reduces
the risk of overweight/obesity while the consumption of simple
carbohydrate-rich food (e.g., sugar-sweetened beverages) is often
associated with increased obesity risk [ 8 , 9 ]. Obesity is involved in
chronic inflammation and inflammation is also related to cellular
senescence, a cell state distinguished by an extended and generally
irreversible cell cycle arrest triggered by multiple stimuli [ 10 , 11 ].
Paradoxically, the presence of senescent cells also has beneficial
effects on the organism. Senescence is involved in physiological
processes such as embryological development [ 10 , 11 ], wound heal-
ing, or tissue regeneration [ 12 , 13 ]. Besides, senescence has been
described as a mechanism to eliminate aberrant cells and can be
considered as an alternative to apoptosis [14] . Hence, taking into
account the important effect of diet on obesity, targeting processes
involved in inflammation, such as senescence, through changes in
diet or dietary supplementation could be a promising approach to
alleviate related disorders. Herein, we highlight molecular mecha-
nisms that promote and perpetuate cellular senescence in obesity.
We also describe the physiopathological diet-induced obesity ef-
fects on the liver, pancreas, or central nervous system (CNS) and
the involvement of senescence as well as dietary approaches to
managing these effects. 
2. Nutrition and immunity 
One of the most energy expending cell systems in the body
is the immune system. Consequently, it is influenced by nutrient
variance, establishing a close link between nutrition and immunity
[15] . Several studies have recognized a relation between nutrition
and macrophages [ 16 , 17 ]. Accordingly, diet acts as a critical reg-
ulatory factor in the immune response: (1) malnutrition can lead
to immunosuppression due to a susceptibility to infection; and (2)
over-nutrition can lead to immune activation or directly to resis-
tance or to an inflammatory condition. Contrarily, any disparity in
the consumption of nutrients and nutritional state can induce un-
favorable consequences. On the other hand, severe under-nutrition
or starvation produces gradual weight loss, a reduction in energy
expenditure and, a diminished metabolic rate and survival [18] . 
Concerning dietary patterns, a high-fat diet (HFD) promotes
weight gain by generating excess fat that leads to an increase in
adipose tissue, inducing hypothalamic inflammation and deregu-
lating homeostasis, and producing insulin resistance, glucose intol-
erance and obesity [19] . It is also known that a HFD creates ex-
cessive body fat accumulation and impairs the immune system.
Indeed, fatty acids such as polyunsaturated, saturated, and trans-
fatty acids are of interest for their effects on inflammatory status
[15] . Other authors have reported that some vitamins and miner-
als present favorable effects on oxidative stress and immune re-
sponses. Moreover, cross-sectional and interventional studies haveconsistently exhibited that vitamins and minerals are related to
several inflammatory markers [C-reactive protein (CRP) and tu-
mor necrosis factor- α (TNF- α)] [15] . By contrast, calorie restric-
tion (CR) promotes health-span, and a plethora of CR mimetics
have been used to imitate its helpful effects by regulating mito-
chondrial metabolism or autophagic flux, suppressing inflamma-
tory processes, protecting intestinal barrier function, and reducing
both inflammation and neuroinflammation [20] . 
In conclusion, optimal nutrition is vital for healthy immune
homeostasis, however, dietary patterns such as HDF, unbalanced
diet, or over-nutrition are related to inflammation and may lead
to obesity. 
3. Inflammation and senescence 
Cellular senescence is a cellular state presenting extended and
generally irreversible cell cycle arrest triggered by multiple stim-
uli [ 21 , 22 ]. Importantly, once cells become senescent, they produce
and secrete the so-called senescence-associated secretory pheno-
type (SASP). Broadly, SASP is composed of pro-inflammatory cy-
tokines and chemokines, growth factors, proteases, and angio-
genic factors that can act in a paracrine and autocrine manner to
spread and strengthen senescence [ 23 , 24 ]. The presence of SASP-
producing senescence cells can have negative long-term effects
such a chronic inflammation, which can produce tissue dysfunc-
tion and/or carcinogenesis [ 25 , 26 ]. 
Senescence is a dynamic process with multiple steps [27] . The
initiation of senescence is characterized by early signals that are
sufficient to initiate processes such as oncogene activation or DNA
damage. In early senescence, the chromatin of senescent cells is
gradually altered and there is a loss of Lamin B1, changes in lyso-
somal activity and autophagy. These senescent cells develop SASP
and the distinguished senescence-associated β-galactosidase (SA-
β-gal) activity to enter into a final step of full senescence. Senes-
cent cells that persist in the aforementioned step for long periods
can be classified in a final step called late senescence, in which
the senescent phenotype adapts and progresses with chronic in-
flammation [26] ( Fig. 1 ). 
SASP is regulated by a wide range of elements, such as sig-
naling molecules [p38, mammalian target of rapamycin (mTOR),
and Notch], transcription factors [nuclear factor kappa-light-chain-
enhancer of activated B cells (NF- κB), CCAAT/enhancer-binding
protein- β (c/EBP- β), GATA binding protein 4 (GATA4), and epige-
netic regulators (euchromatic histone-lysine N-methyltransferase 2
(EHMT2 or G9a), G9a-like protein (GLP), MacroH2A, high-mobility
group box 2 (HMGB2), mixed lineage leukemia protein-1 (MLL1),
bromodomain-containing protein 4 (BRD4), H2A.J] [28] . Cell cycle
withdrawal and subsequent entry into senescence can be mediated
by many molecular pathways, depending on the senescence stim-
ulus, but all of the pathways seem to converge in the activation of
the cyclin-dependent kinase (CDK) inhibitor P21 WAF1/Cip1 [29] . 
In summary, inflammation is intrinsically related to cellular
senescence mainly through the pro-inflammatory factors of SASP.
Thus, senescence might contribute to inflammation related to obe-
sity, and targeting senescent cells might be a therapeutic approach
to reducing pro-inflammatory responses in obesity-related disor-
ders. 
4. Obesity and senescence 
Obesity and obesity-associated hyperglycemia and metabolic
stress can trigger senescence of a plethora of cell types. Impor-
tantly, HFD-associated hyperglycemia and dyslipidemia can also in-
duce senescence [ 30 , 31 ]. Accordingly, the mean telomere length, a
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Fig. 1. Physiopathological diet-induced obesity effects on the liver, pancreas, and central nervous system and the involvement of senescence as well as main approaches to 
managing their impact on health. Abbreviations: DNA, deoxyribonucleic acid; HCC, hepatocellular carcinoma; NAFLD, non-alcoholic fatty liver disease; NASH, nonalcoholic 






























































marker of cellular senescence, was reduced up to 30% in cardiomy-
ocytes of older (normal-weight and obese) and younger obese sub-
jects, showing the shortest telomeres in the older obese group
[32] . Thus, individuals with higher total and abdominal adiposity
have lower telomere length [ 32 , 33 ]. Adults with severe or mor-
bid obesity present shorter telomeres compared with eutrophic
subjects, mainly due to telomeric repeat factor 1 (TRF1), one of
the components of the shelterin complex also known as telosome
(a protein complex known to protect telomeres in many eukary-
otes from DNA repair mechanisms and the regulation of telom-
erase activity [34] , and insufficient antioxidant adaptive responses
to compensate for oxidative stress and telomeres attrition. Addi-
tionally, the obesity status of para-inflammation might promote an
increased rate of proliferation of hematopoietic precursors in the
bone marrow, expansion and proliferation of leukocytes in periph-
eral sites prompting leukocyte senescence and, finally, a reduction
in telomeres [35] . 
Obesity is a complex disorder and a major risk element for
many diseases and several health problems. Based on the current
data, senescent cell clearance might be a suitable tool to treat
obesity-related disorders. 
5. Gut microbiota, diet and senescence 
The gut microbiota (a complex dynamic population of microor-
ganisms including viruses, bacteria, archaea, fungi or protists) is
of relevance for research related to diet and metabolic health. A
body of evidence has described the gut microbiota as a mediator
of dietary impact on host metabolic status [36] taking into account
that: (1) diet is considered to be one of the main modulators of
the gut microbiota; (2) intestinal bacteria are crucial for maintain-
ing immune and metabolic homeostasis, and (3) the gut microbiota
plays a protective role against pathogens [37] . 
In this regard, some dietary compounds affect aging through
modification of the gut microbiota. For example, fiber decreases
inflammation, hypertension and obesity, while saturated fats in-
crease inflammation, atherosclerosis and obesity, and polyphenolsreduce inflammation and have antioxidant effects. These outcomes
are the consequences of changes in the bacterial composition of
the microbiota [38] . 
An altered intestinal microbial (dysbiosis) profile produces in-
testinal permeability and is associated with the pathogenesis of
numerous inflammatory diseases and infections [37] . In this re-
spect, the mature intestine renews quickly along life being the
principal factor for intestinal epithelium self-renewal the Wnt-
mediated signaling pathway [39] . 
Remarkably, the gut microbiota can influence senescence in var-
ious organs [40] and both genetic and nutritional obesity steer
variations in the composition of the gut microbiota, accompa-
nied by alterations in intestinal physiology, metabolites, and en-
docrine factors [ 41 , 42 ]. In this regard, it has been reported that
methylglyoxal, a bacteria-derived metabolite, accelerated cellular
senescence in human dermal fibroblasts and regulated longevity
of Caenorhabditis elegans by targeting rapamycin complex-2/serum-
and glucocorticoid-inducible kinase homolog 1 (TORC2/SGK-1) in-
hibition and DAF-16 activation [43] . In a model of liver cancer
in obese mice, obesity-induced imbalance of the intestinal micro-
biota led to higher levels of the microbiota-derived secondary bile
acid deoxycholic acid and Gram-positive gut microbial component,
lipoteichoic acid. These compounds induced senescence of hepatic
stellate cells (HSCs) and the secretion of pro-inflammatory SASP,
creating a pro-tumorigenic microenvironment [ 44 , 45 ]. 
To summarize, the gut microbiome exerts a critical influence
on several facets of human health including metabolic regulation,
energetic homeostasis, immune response, or gut barrier integrity,
although the interrelation between the complex triad formed by
diet, senescence and the microbiota is still un-deciphered. Research
about the impact of microbiota profiles in cellular senescence is
mandatory. 
6. Diet, aging and senescence 
Cellular senescence is a hallmark of aging [46] . In turn, aging is
affected by diet, as well as genetic and psychological factors [47] . It










































































































has been suggested that many foods and dietary compounds pro-
mote or impede healthy aging, i.e., longevity accompanied by the
quality of life what highlights the idea that the maintenance of a
healthy diet is a key strategy to improve lifespan and health-span. 
The Mediterranean dietary pattern (typical in countries such as
Spain, Italy and Greece) considered as a whole, as well as by spe-
cific components, including olive oil, fruits, vegetables, tomatoes,
fish or fish oil, nuts, red wine, folate and polyphenols, positively
affects all the hallmarks of aging [48] . Since aging is related to an
increase in oxidative stress and the subsequent production of re-
active oxygen species (ROS), an increment in the intake of dietary
antioxidants, such as adaptogens, anthocyanins, isoflavones and vi-
tamins A, D, C and E (which are found in high quantities in plants)
delays the aging process [49] . Vitamin D and calcium [50] , as well
as dietary phosphorus [51] support bone health, and therefore,
healthy aging. Furthermore, vitamin C, vitamin E, carotenoids (vita-
min A, β-carotene, astaxanthin and retinol), vitamin F, polyphenols
(mostly found in fruits and plant-derived foods), ubiquinol (coen-
zyme Q10), prebiotics and probiotics protect against skin aging
[52] . In addition, specific dietary compounds, including antioxidant
trace elements (zinc and selenium), insulin sensitizers (chromium
and zinc) and polyphenols, have been shown to prevent brain ag-
ing [53] . 
On the other hand, low dietary protein intake seems to induce
loss of muscle mass and accelerates aging [54] . Whether branched-
chain amino acids (leucine, valine and isoleucine) have a positive
or negative influence on the aging process is not clear, and may
be due to the fact that they act as signaling molecules, leading to
different outcomes in different biological contexts [55] . 
6.1. Fatty acid composition of the diet and aging 
Concerning the relation to aging and the type of dietary fat, not
all types of fat would have the same effect. For instance, a study
carried out on animals showed that consumption of HFD is asso-
ciated with accelerated aging, unfortunately, the authors did not
specify the type of fat consumed [56] . By contrast, the consump-
tion of a Mediterranean diet rich in monounsaturated fats had a
protective effect on cellular senescence compared to diets with a
high content of saturated fats [57] . Also, the type of fat modulated
the response to aging in several tissues. A study carried out in rats
found that consumption of sunflower oil resulted in higher lev-
els of cytochrome b (associated with increased aging) compared to
olive oil consumption [58] . Concerning the brain, preclinical mod-
els have shown that this organ could be negatively affected by sat-
urated and trans-fat [ 59–61 ]. It has been reported that maintaining
a balance between docosahexaenoic acid (DHA) and polyunsatu-
rated fatty acid (PUFA) n-6 arachidonic acid (20:4n-6) in the brain
membrane is crucial for normal CNS function [ 62–64 ]. Likewise,
dietary supplementation with arachidonic and DHA can improve
aging-related cognitive dysfunction [65] , and dietary n-3 PUFA has
been associated with delayed cognitive decline in a senescence-
accelerated prone 8 mouse model (SAMP8) [66] . Conversely, a
study carried out by Inoue et al. revealed that the consumption of
fatty acids such as palmitic acid-induced cellular senescence and
lipid accumulation in hepatocytes [67] . Further, the consumption
of fish oil rich in ω-3 polyunsaturated fatty acids may promote ag-
ing and oxidative stress in the SAMP8 mouse model [68] . Nonethe-
less, fish oil consumption was associated with an increase in lifes-
pan (higher than 40%) in females (NZB x NZW)F(1) a mouse model
prone to autoimmunity [69-71] . In the same line, the study carried
out by García-Esquinas et al . in a cohort of 1,592 individuals older
than 60 years showed that the increment of bluefish consumption
was negatively associated with unhealthy aging, and the intake ofeicosapentaenoic acid (EPA) and DHA led to a protective effect in
age-related deficits [72] . 
Altogether it is important to remark that the fat source, and its
composition, may influence senescence and, in consequence, the
aging process. 
6.2. The relevance of calorie restriction (CR) in overweight and 
obesity from the point of view of aging 
CR is understood as a decrease in caloric intake without leading
to malnutrition. In the present section, we remark on some studies
and results in this regard. 
Monkeys subjected to 30% CR for more than 20 years found
contradictory results in terms of lifespan extension. These con-
flicting results might be explained by the different monkey breeds
used and the type of feeding [ 73 , 74 ]. Another study by Liao et al.
performed in 41 recombinant strains of mice subjected to a CR reg-
imen of 40% suggested a greater reduction in adiposity and shorter
lifespan in these animals [75] . However, the authors did not in-
clude an assessment of health indicators, causes of death, or other
underlying mechanisms that could be involved. By contrast, several
studies have shown that a reduction in caloric intake of 20–40%,
prevents age-related diseases and increases lifespan and/or health
[76] . Unfortunately, no data in humans on the relationship between
CR and longevity, so surrogate measures have to be used. In this
line, CR for 6 months, with or without exercise, in overweight,
non-obese (body mass index, 25 – 30) men and women reduced
2 biomarkers of longevity (fasting insulin level and body tempera-
ture) [77] . Besides, CR by diet alone or with exercise reversed lipid
deposition in visceral and hepatic tissues in a study conducted in
48 overweight volunteers [78] . Importantly, D Ard et al. found that
a moderate CR (reduction of 500 Kcal/day) reduced total body fat
and cardiometabolic risk factors without significant adverse events
and lean mass loss in obese adults [79] . 
In C57Bl/6 (ICRFa) mice subjected to CR the authors observed
a positive change in senescence and inflammation markers [80] .
Remarkably, Harrison et al . found that obese mice subjected to CR
lived longer than lean mice fed ad libitum [81] . These results could
be a consequence of a reduction of the energy imbalances and the
effect of a higher fat accumulation in obese mice compared to lean
ones [82] . Notwithstanding due to the molecular mechanisms link-
ing adipose tissue and longevity are not yet fully understood it
is difficult to separate CR-associated benefits and those from re-
duced adipose tissue mass and leanness. In this regard, some stud-
ies show that weight loss increases mortality compared with its
maintenance [ 83–85 ]. This might be likely explained given that
losing weight is not the same as losing body fat. Selective fat loss
is associated with reduced mortality [86] , whereas loss of fat-free
mass is deleterious and responsible for the excess mortality follow-
ing weight loss [87] . 
In conclusion, CR could be considered as a solid and effective
tool to delay aging and its harmful consequences. However, re-
ported studies in this regard show inconclusive data. 
7. Obesity-associated tissue and organ disorders and 
senescence 
Obesity is connected to alterations in the function of several
organs such as adipose tissue, liver, pancreas, or the nervous sys-
tem. This section summarizes studies describing the relationship
between these organs and senescence in the context of obesity as
well as the effect of some dietary patterns. 





















































































































7.1. Adipose tissue 
The adipocytes and immune cells, including macrophages and
T cells, secrete a large spectrum of inflammatory mediators favor-
ing a local inflammatory niche in adipose tissue that contributes
to low-level systemic inflammation [88] . However, while it is not
completely understood how obesity triggers inflammation, one hy-
pothesis proposes that the overburden of nutrients in adipocytes
promotes intracellular stress resulting in the activation of inflam-
matory cascades [ 15 , 89 ]. 
The concept that adipose tissue is a simple fat storage space
has changed over the last years towards its present considera-
tion as an organ with multifunctional secretory function [90] . Ma-
ture adipocytes are required in endocrine, paracrine, and autocrine
regulatory processes by the secretion of several multifunctional
molecules known as adipokines. Adipokines can modify physiologi-
cal processes, such as hematopoiesis, reproduction, and feeding be-
havior, and may mediate the genesis of a wide number of patholo-
gies related to an expanded fat mass [91] . 
Concerning senescence, in obesity, there is an accumulation of
senescent cells in a mouse model [92] . Fat tissue is rich in pro-
genitors able to produce pro-inflammatory factors susceptible to
cellular senescence. Possibly, senescence is an alternative cell fate
that has much in common with pro-inflammatory stress-activated
states. Consequently, inflammatory processes related to cellular
senescence in fat tissue may be crucial [93] . 
The presence of senescent cell markers in adipose tissue is as-
sociated with detrimental effects. Thus, the presence of an elevated
burden of senescent cell biomarker cyclin-dependent kinase in-
hibitor p16 INK4a , within adipose tissue, leads to detrimental effects
associated with poorer physical function in older persons [94] . The
pro-inflammatory state associated with cellular senescence is more
evident in omental than subcutaneous fat-derived endothelial cells,
perhaps contributing to regional differences in fat tissue functions
in obese adults [95] . These changes involve long-term activation of
the protein kinase Akt in mice [96] . Although senescence is asso-
ciated with aging [ 97 , 98 ] and dysregulated activation of fat tissue
in obesity, immune responses might lead to the same metabolic
dysfunction in a mouse model [92] . 
Obesity-associated bone fragility can be related to improved in-
sulin signaling and enhancement of adipocytic progenitor cells in
the bone marrow. These variations lead to augmented glucose use
and an improved mitochondrial oxidative phosphorylation system
(OXPHOS), generating ROS and producing bone marrow stromal
stem cells exhaustion as well as the creation of a senescent bone
marrow microenvironment conducive to bone fragility in a mouse
model and bone marrow stromal stem cells from lean, overweight,
and obese subjects [ 92 , 99 ]. In mice, reduced senescence was ob-
served in obesity and was related to adipogenesis and decreased
adipose tissue dysfunction showing that a reduction in senescent
cell burden in obese mice led to alleviating important elements
of obesity-related metabolic dysfunction, such as improved glu-
cose tolerance, enhanced insulin sensitivity, lowered circulating in-
flammatory mediators, and the promotion of adipogenesis [100] .
Additionally, zinc finger protein 521 (ZNF521), a transcription co-
factor with recognized regulatory functions in human hematopoi-
etic, osteo-adipogenic, and neural progenitor cells, seems to be vi-
tal in the regulation of cell cycle [101] , and knockdown embry-
onic fibroblast mouse cell line 3T3-L1 deleted in breast cancer
1 (DBC-1) gene (a gene related to senescence) showed increased
senescence-related markers in adipose tissue [102] . 
Senescence also activates peroxisome pro-liferator-activated re-
ceptor gamma (PPAR- γ ), a crucial regulator of primary human adi-
pose tissue endothelial cell function including fatty acids, driv-
ing inflammatory response which might impact adipose tissuefunction in human adipose tissue samples [103] . Finally, human
obesity causes premature senescence in adipose tissue-derived
mesenchymal stem cells. Thus, the obesity-induced cellular injury
might alter the efficacy of this endogenous repair system and ham-
per the feasibility of autologous transplantation in obese individu-
als [104] . In Table 1 we summarize findings in the literature about
adipose tissue and senescence. 
A HFD produces preferential enlargement and accumulation of
CD44 hi CD62L lo CD4 + T cells that constitutively express cell death
protein 1 (PD-1) and CD153 in a B cell-dependent manner in
murine visceral adipose tissue [105] . These cells possess charac-
teristics of cellular senescence and demonstrate high activation of
secreted phosphoprotein 1 (Spp1) (encoding osteopontin [OPN]) in
visceral adipose tissue [105] . 
In addition, certain dietary patterns are able to decrease
lipopolysaccharide (LPS) activity in humans [106] . In turn, LPS de-
creases adipogenesis through disrupting preadipocyte differentia-
tion that is independent of LPS stimulation of the NF- κB path-
way and cytokine production in murine adipose tissue [107] . On
the other hand, mesenchymal stem cells from obese subjects re-
vealed a lower proliferative function compared to those from non-
obese individuals. The senescent cell phenotype was characterized
by up-regulation of p16, p53, IL-6, and MCP-1 gene expression in
obese subjects. The body mass index corresponds directly with the
p16, p21, and IL-6 expression cyclin-dependent kinase inhibitor p16
(p16), p53, IL-6, and monocyte chemoattractant protein-1 (MCP-
1) gene expression in obese subjects. Body mass index corre-
sponds directly with the p16, cyclin-dependent kinase inhibitor 1A
(CDKN1A or p21) [104] . Embryonic rat osteogenic calvarial cells
from HFD obese dams and human umbilical cord mesenchymal
cells showed overexpression of p53/p21-mediated cell senescence
signaling but reduced glucose metabolism [108] . Senescence-like
changes were observed in lysosomal dysfunction with changes in
inflammasome activation in white adipose tissue of obese mice
[109] . Female growth hormone receptor antagonist transgenic mice
displayed decreased age-related lipid redistribution and enhanced
insulin sensitivity, but no variation in cellular senescence was ob-
served [110] . 
The above suggests the potential role of cellular senescence on
systemic metabolism and health-span through its effects on fat
tissue. Certain dietary patterns may induce senesce signaling in
adipose tissue, which in turn influences other organs disrupting
homeostasis and leading to several disorders. However, we believe
that there continues to be much debate on the role of senescence
in adipose tissue and its possible relationship with obesity. 
7.2. Liver 
The liver is an accessory digestive organ, meaning that it is not
part of the digestive tract but rather secretes substances into it.
The liver synthesizes and secretes many molecules that have ex-
ocrine (digestive), endocrine, and clotting functions, and it is a key
metabolic organ [111] . It is composed of hepatocytes, HSCs, cholan-
giocytes, liver sinusoidal endothelial cells, and resident immune
cells [112] . Hepatocytes (as shown in human samples [113] ), HSCs
(as shown in murine HSCs[114]), cholangiocytes (as shown in hu-
man cholangiotes [115] ) and liver sinusoidal endothelial cells (as
shown in a rat model [116] ) can enter senescence under certain
conditions. On the contrary, mammalian immune cells are involved
in the clearance of senescent cells [ 114 , 117 ]. Many mechanisms
have been proposed as inductors of HSCs senescence, including IL-
22 in mice [118] , the anti-inflammatory cytokine IL-10 through the
STAT3-p53 pathway in rats [119] , inhibition of Yes-associated pro-
tein (YAP) signaling and subsequent expression of p53 in rodents
[120] , increased activity of p27 promoter and E2F Transcription
6 T. Rubio-Tomás, A. Rueda-Robles, J. Plaza-Díaz et al. / Journal of Nutritional Biochemistry 99 (2022) 108861 
Table 1 
Reported studies about adipose tissue and senescence. 
Senescent cell type Model Effects References 
Senescent cell burden in 
obese mice 
Mice heterozygous for 
transgenes on a C57BL/6 
background maintained on a 
60% (by calorie) fat diet. N = 
8 mice per group 
Elimination of senescent 
cells prevented the 
migration of transplanted 
monocytes into 
intra-abdominal adipose 
tissue and reduced the 
number of macrophages 
Palmer et al . [100] 
Subcutaneous adipose tissue 
stromal vascular fractions 
were CD45 + hematopoietic 
cells, followed by 
CD34 + /CD105 − cells and 
only a few CD105 + /CD34 −
mesenchymal stem cells 
Human 
N = 44 (29 healthy controls 
and 15 were type 2 diabetes 
and first-degree relatives) 
Abdominal subcutaneous 
adipose tissue biopsies 
Increased progenitor cell 
senescence, reduced 
adipogenesis and 
hypertrophic expansion of 
the subcutaneous adipose 
tissue cells in first-degree 
relatives and established 
type 2 diabetes. 
Gustafson, et al . [101] 
Embryonic fibroblast mouse 
cell line 3T3-L1 
Human 
31 subcutaneous and 32 
omental adipose tissue 
samples from morbidly 
obese subjects and 38 
subcutaneous and 42 
visceral adipose tissue 
samples from participants 
with different degrees of 
obesity were studied. 
In vitro : 3T3-L1 cell line 
inhibition of Sirt1 activity 
was associated with human 
adipose tissue senescence in 
morbidly obese subject 
DBC1 increased the NF- κB 
expression in fully 
differentiated 3T3-L1 
adipocytes, possibly by the 
inhibition of Sirt1 activity, 




cells from human adipose 
tissue 
Human: 
N = 67 
Subcutaneous abdominal 
adipose tissue samples from 
nonobese and obese 
subjects 
Accelerated aging is likely to 
participate in adipose tissue 
dysfunction and the 
redistribution of lipids. 




N = 44 
Mesenchymal stromal/stem 
cells harvested from 
abdominal subcutaneous fat 
from obese and 
age-matched non-obese 
subjects during bariatric or 
kidney donation surgeries 
Human obesity triggers an 




Conley, et al. [104] 
Stromal vascular cells, T and 
B cells and macrophages 
Mice C57BL/6 (B6) 
N = 6 mice per group 
A distinct T cell population 
that accumulates in the 
visceral adipose tissue of 
HFD fed obese mice caused 
inflammation of visceral 
adipose tissue by producing 
large amounts of 
osteopontin 
Shirakawa, et al. [105] 
Adipocyte Mice, Inguinal adipose 
tissue of C57BL/6 
Lipopolysaccharide induces 
premature senescence of 
adipocyte progenitors 
Zhao, et al. [107] 
Embryonic rat osteogenic 
calvarial cells, and umbilical 




N = 6 rats per group. 
In vitro : 
Umbilical cord human 
mesenchymal stem cells 
from pregnant women 
Overexpression of p53 
linked increased cell 
senescence signaling and 
decreased glucose 
metabolism in fetal 
osteo-progenitors from 
obese rats and humans 
Chen, et al . [108] 
( continued on next page ) 
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Table 1 ( continued ) 
Senescent cell type Model Effects References 
Adipose tissue Male C57BL/6 mice and 
3T3-L1 cells, N = 6 mice per 
group 
Lysosomal abnormalities in 
adipose tissue, including 
deteriorated cathepsin L 
function and compensatory 
activation of cathepsin B, 
caused cellular senescence 
and inflammasome 
activation 
Mizunoe, et al . [109] 
Adipose tissue Different types of adipose 
tissue from transgenic mice 





None protection against the 
generation of senescent 
cells afforded by decreased 
growth hormone action, low 
insulin-like growth factor 1 
and/or improved insulin 
sensitivity was observed 
Comisford, et al . [110] 
Abbreviations : DBC1, deleted in breast cancer 1; HFD, high-fat diet; NF- κB, nuclear factor kappa-light-chain-enhancer of activated B 


















































































Factor 1 (E2F1) in human cell lines [121] and regulation of the tu-
mor necrosis factor-like weak inducer of apoptosis TWEAK-SIRT1-
p53 axis in human cell lines and primary murine cells [122] or
the insulin-like growth factor IGF-I-p53 axis in mice [123] . Dietary
compounds, such as epigallocatechin gallate (present in green tea)
[124] or curcumin [125] , can also induce HSC senescence when ad-
ministrated to rats, although the molecular mechanisms are not
fully understood. Furthermore, natural killer cells [114] and B lym-
phocytes [126] limit HSC senescence in murine models, with the
subsequent negative impact on fibrosis resolution. Nevertheless,
one study has described a decrease in carbon tetrachloride (CCl 4 )-
induced liver fibrosis in HSC-specific senescence marker protein 30
(SMP30) KO mice [127] . 
Hepatocyte senescence is related to a bad prognosis in patients
with NAFLD [113] and alcoholic liver disease [128] . NAFLD is a
growing cause of chronic liver disease associated with obesity and
metabolic conditions including hypertension, dyslipidemia, and
type 2 diabetes mellitus (T2DM). In obese individuals, exceeded
storage capacity and dysfunctionality of the adipose tissue lead
to the accumulation of lipids in the liver and the development
of NAFLD [ 129 , 130 ]. Aravinthan et al . described a positive inter-
relation between the quantity of P21 WAF1/Cip1 -positive hepatocytes
and fibrosis stage, and hepatocyte telomere length and the grade
of steatosis in NAFLD patients. During the follow-up period, the
percentage of P21 WAF1/Cip1 -positive hepatocytes decreased in pa-
tients with reversed fibrosis but increased in those with worsened
fibrosis. Additionally, patients with more P21 WAF1/Cip1 -positive
hepatocytes, shorter hepatocyte telomere length and a higher
hepatocyte nuclear area (indicators of senescence) had an in-
creased probability of having an unfavorable liver-related outcome
[113] . Accordingly, Ogrodnik et al. found that P21 WAF1/Cip1 -positive
hepatocytes and foci of telomere-associated DNA damage correlate
with the severity of NAFLD [131] . 
Concerning diet, a study performed in rats described the pres-
ence of hepatic senescence in the animals that developed obe-
sity and steatosis on receiving a HFD with 45% kcal from fat, and
high quantities of sugar, including sucrose and maltodextrin [132] .
Ogrodnik et al . showed that long-term ad libitum feeding provoked
hepatic fat increment and hepatocyte senescence in mice. A re-
duction in the liver fat deposition was achieved by the elimina-
tion of cyclin-dependent kinase inhibitor 2A (P16 INK4a ) express-
ing senescent cells in INK-ATTAC transgenic mice fed with a HFD
plus AP20187 treatment and by the administration of a senolyticcocktail containing dasatinib and quercetin. The effect was attained
by the clearance of senescent cells in obese mice carrying a mu-
tation in the leptin receptor. Furthermore, DNA damage-induced
hepatocyte senescence reduced steatosis in vivo and in vitro by
causing mitochondrial dysfunction and reducing fatty acid oxida-
tion capacity [131] . Additionally, accumulating evidence from hu-
man and animal studies suggests that senescence-related proteins,
including ataxia-telangiectasia mutated (ATM) in vitro [133] , and
senescence marker protein (SMP30) in mice [134] , and molecu-
lar mechanisms, such as changes in DNA methylation patterns, ge-
nomic instability, and telomere shortening, might be involved in
the development of steatosis, NAFLD, and non-alcoholic steatohep-
atitis [135] . 
On the other hand, nutraceutical intake and other diet sup-
plements, such as vitamin D, attenuated the initiation and pro-
gression of NAFLD in HFD fed mice. Inhibition of senescence,
quantified by a decrease in hepatocyte senescence-associated β-
galactosidase (Sa βG) staining and in P53, P21, and P16 pro-
tein levels, was observed in animals fed a HFD and treated
with vitamin D, compared to HFD non-treated mice, indicating
that vitamin D affects cellular senescence [136] . The senescence-
accelerated mouse-prone 8 (SAMP8) model was used to test the
efficacy of supplementation with IF dipeptide from potato ex-
tract hydrolysate. The results of this study indicated that swim-
ming exercise training combined with IF administration in HFD
fed SAMP8 mice protected against the effects of the HFD. This
protection included lower hepatic steatosis possibly mediated by
the up-regulation of the phospho-AMP-activated protein kinase
(pAMPK)/SIRT1/ peroxisome proliferator-activated receptor gamma
coactivator 1-alpha (PGC-1 α)/ phospho-forkhead box O3 (pFOXO3)
pathway [137] . 
In hepatic cancer, vitamin C supplementation showed hep-
atoprotective effects in both wild type and SMP30 (involved in
vitamin C biosynthesis) knockout mice treated with diethylni-
trosamine, a widely used liver carcinogen [138] . Using this animal
model of hepatocellular carcinoma Duan et al., described the pro-
tective effects of CR [139] . In humans, the natural alkaloid berber-
ine (found in many plants such as the tumeric tree) reduced cell
proliferation in hepatocarcinoma cells in synergy with X-rays, by
inducing cellular senescence of tumor cells [140] . 
The liver is also an organ affected by cellular senescence in the
context of obesity. Unbalanced diets might promote senescence in
liver cells, initiating or worsening the prognosis of related diseases.
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Table 2 
Reported studies about liver cellular senescence and related disorders. 
Senescent cell type Model Effects References 
Hepatocyte Human, NAFLD 
N = 70 
Hepatocyte senescence 
related to bad prognosis in 
NAFLD 
Aravinthan et al . [113] 
Hepatocyte Mice, C57Bl/6 
N = 9 
Hepatocyte senescence 
related to bad prognosis in 
NAFLD 
Ogrodnik et al . [131] 
Hepatocyte Human, alcoholic liver 
disease 
N = 42 
Hepatocyte senescence 
related to bad prognosis 
alcoholic liver disease 
Aravinthan et al. [128] 
HSC Rats, Wistar 
N = 8 
Epigallocatechin Gallate 
(green tea) promoted 
hepatic stellate cells 
senescence resulting in 
chemopreventive and 
antifibrotic effects 
Sojoodi et al. [124] 
HSC Rats, Sprague Dawley N = 6 Curcumin induced hepatic 
stellate cells senescence 
Jin et al. [125] 
HSC Mice, 
C57/BL6 
N = 12 
Obesity-induced intestinal 
dysbiosis induced 
senescence of HSCs and the 
secretion of 
pro-inflammatory SASP 
Loo et al. [44] , Yoshimoto 
et al. [45] 
Hepatocyte Rats, 
N = 8 
HFD induced obesity and 
steatosis led to Hepatocyte 
senescence 
Zhang et al. [132] 
Hepatocyte Mice, 
N = 5 
Vitamin D decreased 
HFD-induced cellular 
senescence 
Liu et al. [136] 
Hepatocyte Mice, 
SAMP8 
N = 6 
IF dipeptide from potato 
extract hydrolysate 
protected against HFD 
effects 
Asokan et al. [137] 
Hepatocyte Mice, SAMP8 
N = 15 
Vitamin C protected against 
cancer even in the absence 
of SMP30 
Son et al. [138] 
Hepatocyte In vitro , human HSC cell line Calorie restriction protected 
against cancer 
Duan et al. [121] 
Hepatocyte In vitro , Hepatocellular 
carcinoma cell line (HepG2) 
Berberine (tree turmeric) 
induced tumor senescence 
Ramesh et al. [140] 
Abbreviations: HFD; high-fat diet, HSC; hepatic stellate cell, NAFLD; non-alcoholic fatty liver disease, SASP; senescence-associated se- 



































Table 2 summarizes studies about liver cellular senescence and re-
lated disorders. 
7.3. Pancreas 
The islets of Langerhans are scattered throughout the aci-
nar parenchyma and perform endocrine functions. Each islet con-
sists of a core of β cells that produce insulin, surrounded by
α cells, δ cells, ε cells, and polypeptide (PP) cells that secrete
glucagon, somatostatin, ghrelin, and pancreatic polypeptide, re-
spectively [ 141 , 142 ]. Loss of functional β cell mass produces dia-
betes, being Type 1 (T1DM) and T2DM the main types. T1DM is an
autoimmune disease while T2DM is mediated by metabolic mech-
anisms, including obesity. In T2DM excessive lipid storage leads
to insulin resistance and systemic inflammation contributing to its
development [ 129 , 143 ]. 
In humans, T2DM donors present a higher percentage of SA-
β-gal-positive senescent cells in the islets [144] . In rodents, Sone
et al. showed that long-term diabetes induced by HFD reduced
proliferating β cells, decreased insulin production, and increasedpancreatic senescence [145] . Moreover, mice subjected to
metabolic stress, i.e. hyperglycemia and hyperinsulinemia caused
by treatment with an insulin receptor antagonist, displayed in-
creased P16 INK4a islet expression [146] . Importantly, these murine
senescent β cells synthesized and produced SASP. In turn, P16 INK4a
seems to hamper the regenerative potential of pancreatic islets
in this murine model [147] . Islets senescent clearance improved
glucose tolerance and β cell functionality in HFD fed mice [144] .
Notably, T2DM and obesity are important risk elements for pan-
creatic cancer [148] , although the role of senescence in their
development is unclear [149] . 
A high intake of red and processed meat, sugar, and artificially-
sweetened drinks accelerate the onset of T2DM, while diets en-
riched in dietary fiber, olive oil, whole grain, low-fat dairy prod-
ucts, magnesium, and flavonoids, among others, as well as specific
dietary patterns such as the Mediterranean can prevent its appear-
ance [150] . In addition, serum 25-hydroxyvitamin D levels may be
linked to increased fat mass and impaired glucose metabolism in a
healthy aged population [151] . Results from Cheng et al. in mice in-
dicated that CR could be a potential treatment for both T1DM and
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Table 3 
Reported studies about pancreas cellular senescence and related disorders. 
Senescent cell type Model Effects References 
B cells Human, T2DM, N = 49 
Mice, C57BL/6 N = 4 
Increased SA- β-gal-positive 
senescent cells in T2DM 
Better β cell functionality in 
HFD fed mice after 
clearance of senescent cells 
Aguayo-Mazzucato et al. 
[144] 
B cells Human, T2DM, N = 49 
Mice, C57BL/6 N = 4 
Hyperglycemia and 
hyperinsulinemia increased 
β cells senescence 
Aguayo-Mazzucato 
et al. [146] 
Whole islets of Langerhans Mice, C57BL/6J N = 8 HFD-induced diabetes 
increased pancreatic 
senescence 
Sone and Kagawa [145] 
Whole islets of Langerhans Mice 
N = 7-23 
Senescence diminished the 
regenerative potential of 
pancreatic islets 
Krishnamurthy et al. [147] 
Whole islets of Langerhans Mice, SMP30 KO, N = 7 Altered insulin release 
patterns after glucose 
stimulation 
Senmaru et al. [153] 
Abbreviations: HFD, high-fat diet; KO, knockout; SA- β-gal, senescence-associated beta-galactosidase; SMP30, senescence marker 
protein-30; T2DM, Type 2 diabetes. N means the number of subjects. 
Table 4 
Reported studies about CNS cellular senescence and related disorders. 
Senescent cell type/Place Model Effects References 
Astrocytes In vivo : Rats, Wistar 
N = 4 
Acidic fibrillary protein 
(GFAP)-positive: flat 
morphology with aging 
Mansour et al [164] 
Astrocytes In vivo : Rats, Wistar 
N = 4 
Acidic fibrillary protein 
(GFAP)-positive: flat 
morphology with aging 
Mansour et al [164] 
Microglia In vitro : Microglia from 
newborn rats 
(Specie = NI) 
Telomere shortening with 
advancing age 
Flanary et al. [165] 
Astrocytes In vitro : Human and mouse 
astrocyte 
(Specie = NI) 
Cellular senescence in 
response to stressors 
Bitto et al. [166] 
Neuron-glia In vitro : Primary 
mesencephalic neuron-glia 
from C57BL/6 mouse 
embryos 
Environmental paraquat and 
iron exposure might induce 
senescence 
Peng et al. [167] 
Glial cells In vivo : Mice, C57BL/6 
N = 6 
Senescent glial cells favored 
the excess of fat deposits 
accumulation 
Ogrodnik et al. [92] 
Paraventricular nucleus In vivo : Mice, C57BL/6 
N = 4 
Obesity-related senescence 
induction 
Subramanian et al. [168] 
Hypothalamus In vivo : Mice, INK-ATTAC 
N = 5-6 
HFD increased senescent 
cells number 
Ogrodnik et al. [92] 
Hippocampus In vivo : Mice, C57BL/6 
N = 11 
HFD/high-fructose promoted 
cell senescence 
Jang et al. [177] 
Astrocytes In vitro : Astrocyte from 
2-d-old SAMP8 and SAMR1 
mice 
CR decreased senescence García Matas et al. [182] 
Brain slices In vivo : Zebrafish 
N = 10 
SA- β-gal level was not 
modified by diet 
Arslan-Ergul et al. [183] 
Cerebrum In vivo : Mice, 
SAMP10 
N = 7-11 
35 mg/kg/day green tea 
catechin suppressed the 
level of oxidative damage to 
DNA, 
Unno et al. [186] 
Abbreviations: CR, calorie restriction; HFD, high-fat diet; GFAP, glial fibrillary acidic protein; SA- β-gal, senescence-associated 
β-galactosidase; SAMR1, senescence-accelerated-resistant mice; SAMP8, senescence-accelerated mouse-prone 8; SAMP10, senescence- 
accelerated mouse prone 10. N means the number of subjects; NI: not indicated. 

























































































































T2DM [152] . However, to date, none of these foods and diets has
been related to a decrease in cellular senescence in the pancreas,
although it has been shown that islets from SMP30 knockout mice
present different insulin release patterns after glucose stimulation.
Nevertheless, further research is needed to evaluate the implica-
tion of cellular senescence in this pathology [153] . In Table 3 we
summarize studies about pancreas cellular senescence and related
disorders. 
The above-mentioned studies indicate that diabetes is likely to
be a risk factor for the production of senescent cells and should be
taken into account as a key player in regulating their development.
In addition, certain diets seem to have a protective role in the de-
velopment of diabetes, which, in turn, could be a barrier to the
appearance of senescent cells. However, more studies are needed
to address this issue. 
7.4. The central nervous system (CNS) 
Among other systems, the CNS is involved in the organic control
of dietary intake and participates in short- and long-term energy
balance by receiving signals from the body’s energy state [154] .
Various factors act at the CNS level to stimulate or inhibit food
intake such as leptin, insulin, or glucagon-like peptide 1 [155] . The
hypothalamus integrates peripheral signals which modulate food
intake and energy expenditure arising from the arcuate nucleus,
the paraventricular nucleus, the lateral hypothalamic area (consid-
ered to be the center of appetite), the ventromedial nucleus (center
of satiety), and the dorsomedial nucleus [156] . Thus, lesions caused
in these regions can modify food intake producing obesity and hy-
perphagia [157] . 
The CNS is composed of the brain and the spinal cord. The
first coordinates a multitude of functions, ranging from physical
movement to hormone secretion, whereas the spinal cord runs
along the back of the body and carries information between the
brain and the body, among other functions [ 158–160 ]. Currently,
the study of senescence in the CNS is an innovative concept fo-
cused on its role as a contributor to neurodegenerative diseases.
Although the mechanisms underlying cellular senescence in the
brain remain unclear, it has been demonstrated that different types
of CNS cells can become senescent [ 161 , 162 ]. One of the most stud-
ied cell type is astrocytes. It has been reported that in an experi-
mental in vitro ageing model in which astrocyte-enriched primary
cultures were established from 2-day-old Fischer 344 rat brain cor-
tical tissue rats, cultured astrocytes stained positive for the senes-
cence marker senescence-associated beta-galactosidase (SA-Bgal) 3
months later [163] . Moreover, results from an in vivo experimental
model in which astrocytes were analyzed in retinal whole-mount
preparations from Wistar rats aged 3 months (young adult) to 18
months (aged), showed that ageing is associated with glial fibril-
lary acidic acidic protein (GFAP)-positive astrocytic cells, showing
a flat morphology typical of senescent cells [164] . Concerning mi-
croglia, some observe that with advancing age, telomere shorten-
ing occurs, and this can lead to senescence. In this study using an
in vitro model of microglia isolated from the brains of newborn
rats, authors observed that telomere shortening in microglia is ac-
companied by their progression towards senescence by 32 days
of its in vitro cultured [165] . Not only aging but also other fac-
tors are related to senescence in the CNS, as senescence in human
and mouse astrocytes occurs in response to several stressors as
showed this study using an in vitro model of human astrocytes and
primary cultures of astrocytes prepared from forebrains of 3-day-
old mice [166] , whereas environmental paraquat and iron exposure
could induce senescence in neuron-glia culture cells (in this case
were used primary mesencephalic neuron-glia cultures from em-
bryonic gestation day 14–15 C57BL/6 mouse embryos) [167] . TheCNS is also closely related to obesity and senescence [131] , and it
has been suggested that obesity might induce senescence in the
paraventricular nucleus [168] . 
Additionally, an in vivo study carried out by Ogrodnik et al.
[92] in a model of C57Bl/6 mice fed with HFD showed an accu-
mulation of senescent glial cells with an excess of fat deposits
next to the lateral ventricle, generating obesity-induced anxiety
[92] . Palmer et al. [169] suggest that there may be a link between
the increased risk of cognitive impairment caused by diabetes and
senescence in the brain, but there are no studies on this aspect. On
the other hand, elevated p53 and ROS values have been observed
in obese mice and in patients with Parkinson’s disease [ 170–172 ].
Since the activation of p53 produced by a transitory stop of the
cell cycle is due to the beginning of senescence as a consequence
of a cell insult [173] , it has been suggested that obesity may in-
crease the risk of developing this disease [ 170–172 ]. Nonetheless,
more studies are required to determine if increased p53 activation
as a consequence of obesity increases cell senescence and finally
leads to Parkinson’s disease . 
As far as diet is concerned, an unbalanced diet according to
calories ingested with an intake that exceeds caloric expenditure,
resulted in the reduction of oxygen to the superoxide ion [174] .
ROS production can induce premature senescence causing persis-
tent DNA damage which can injure neurons [175] . In this regard, a
significant increase in senescent cells was observed in the hypotha-
lamus of an in vivo model of INK-ATTAC mice fed with HFD [92] . As
suggested by Golde et al. [176] , the environment caused by these
kinds of diets would generate senescent changes in neuroglial stem
cells, the glia, as well as endothelial and smooth muscle cells that
form the cerebrovasculature. In this line, Jang et al. [177] deter-
mined in an in vivo study that a HFD/high-fructose diet promoted
cell senescence in the hippocampus in female C57BL/6 mice. On
the contrary, endurance exercise entirely reversed cell senescence
in a group subjected to the same diet. These authors also showed
a reduction in interleukin-1 β (IL-1 β) and TNF- α levels induced by
the diet plus the endurance exercise. Despite these promising re-
sults, more studies are necessary to confirm the mechanisms by
which HFDs advance neuronal senescence. 
On the other hand, CR has anti-inflammatory properties such
as pro-inflammatory mediator suppressors (i.e. NF- κB, IL-1 β , IL-6,
TNF, cyclooxygenase 2, and inducible nitric oxide synthase) delay-
ing brain senescence and preventing neurodegeneration [ 178–180 ].
CR also can suppress oxidative stress and damage. An in vivo study
carried out in rhesus macaques ( Macaca mulatta ), reported that CR
could promote health and delay the progression of neuronal aging
in several brain areas [181] . The effect of CR on astrocyte senes-
cence has also been studied using a CR in vitro model as of pri-
mary cultures enriched in astrocytes obtained from cerebral corti-
cal tissue from 2-d-old SAMP8 and SAMR1 mice and cultured dur-
ing 21 d, revealing decreased senescent astrocytes due to CR and
a reduction in β-galactosidase activity related to replicative-type
senescence [182] . In contrast, the in vivo study in young and older
adult zebrafish (wild-type AB strain) carried out by Arslan-Ergul
et al. [183] concluded that diet did not change the signal levels of
the senescence marker SA- β-gal in brain slices. 
It is widely known that diets with high saturated fats, trans fats,
or refined sugars produce pro-inflammatory substances and pro-
mote the development of chronic inflammatory diseases [ 184 , 185 ].
The use of green tea catechin (35 mg/kg/d, similar to 10 cups of
green tea per day by person) in an in vivo male mouse model of
accelerated senescence (SAMP10), suppressed the level of oxidative
damage to DNA, indicating that dietary antioxidants could be an
important key to arresting or mitigating the effects of senescence
in the brain [186] . Finally, dietary antioxidants have shown preven-
tative effects on oxidative stress [ 187 , 188 ]. In Table 4 we summa-
rize studies about CNS cellular senescence and related disorders. 






























































































Further studies are needed to elucidate the mechanism of ac-
tion by which senescence occurs in the CNS, but it seems that obe-
sity may play an important role not only in the development of
senescent cells but also in neurodegenerative diseases. In addition,
the CNS controls food intake, and damage caused by senescence
could mean that increased food intake leads to fat accumulation
and obesity. 
8. Conclusions 
Nowadays, a sedentary lifestyle and the progressive adoption of
the Western diet are enhancing the development of obesity. Senes-
cence status and obesity share a pro-inflammatory activated state
that promotes alterations in the physiology of several organs and
tissues promoting an unhealthy status. SASP is compound by pro-
inflammatory factors that overlap with those secreted by adipose
tissue. 
The above mentioned studies suggest that dietary-mediated
senescence is involved in liver disease, diabetes, CNS disorders and
intestinal dysbiosis, suggesting that cellular senescence may be an
alternative circumstance in pro-inflammatory responses and might
be used for therapeutic purposes. In this line, nutraceutical supple-
mentation (e.g., vitamins or plant-derived compounds) as well as
CR, have been adopted as effective interventions for obesity treat-
ment and related pathologies, albeit with contradictory results. We
believe that there are still many controversies related to the role
of senescence in adipose tissue and its relationship with obesity,
and the medical literature is fraught with problems of uncontrolled
observations in nutrition. Unfortunately, to date, the role of senes-
cence in obesity is far from clear. 
Thereby, to contrast the contradictory reported results it is
mandatory to characterize the precise processes associated with
cellular senescence and also the implication of diet and obesity so
as to assist within the development of therapies and dietary inter-
ventions for the treatment of obesity and connected diseases. 
8.1. Closing remarks 
In the present review, we highlight recent literature regarding
nutrition and cellular senescence in obesity-related disorders cov-
ering studies conducted in vitro , humans and animal models. We
discuss the impact of an unhealthy diet on tissues affected by obe-
sity, and the mechanisms that promote inflammation and senes-
cence. 
Some aspects seem clear and the scientific community has
reached a consensus on them. Namely: (1) optimal nutrition is vi-
tal for healthy immune homeostasis; (2) dietary patterns such as
HDF, unbalanced diet, or over-nutrition are related to inflamma-
tion and obesity; (3) inflammation is linked to cellular senescence
through the pro-inflammatory factors of SASP; (4) senescence is
associated with aging. 
However, many controversies and contradictory results have not
been elucidated yet. In our view aging, senescence, response to nu-
trients, immunity, and inflammation present differences not only
between species but also because of the stimulus that triggers it
and the used model in the study (in the case of animal models or
in vitro approaches). In consequence, differences in the modulation
of signaling and related pathways are expected which would ex-
plain at least partly discrepancies and controversial results. Further,
it exists a wide heterogeneity in the human population (e.g., sex,
location, age, ethnicity or weight) that together with factors such
as environment, psychological stress factors, or genetics should bealso considered to evaluate results and extract conclusions. In addition to the mentioned factors, senescence and/or immu-
nity response can be induced by many other different intrinsic and
extrinsic insults, such as oncogenic activation, oxidative and geno-
toxic stress, mitochondrial dysfunction, irradiation or chemothera-
peutic agents, even microbiota profile need to be considered due
to several studies suggest that it is unique to each individual. Hav-
ing these into account, overall, animal models are very helpful
to overcome, difficulties from human studies. Other advantages of
studies performed in animals are their reproducibility, reliability
or their, affordable and technical availability. However, we should
only compare those studies carried out with similar animal models
and standardized protocols, as well as those that mimic the clinical
scenario as much as possible. 
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